Company intelligence / Profile preview

Anhui Huaerkang Pharmaceutical

Anqing, Anhui, China

Ownership: Private
Employees: ~249
Development stage: Other

Overview

Anhui Haikang Pharmaceutical is a high-tech Chinese pharmaceutical company specializing in the research, development, production, and sales of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on antiviral, antitumor, hypoglycemic agents, anti-allergic drugs among other therapeutic areas. It supplies both domestic and international markets with commercial-scale APIs such as ganciclovir, imatinib mesylate, sitagliptin phosphate monohydrate/vildagliptin/empagliflozin/ibrutinib/favipiravir/valacyclovir HCl/tofacitinib citrate/loratadine/trimebutine maleate/allopurinol/silodosin/niraparib/baricitinib/etc.

Therapeutic areas: Infectious DiseasesImmunologyEndocrinologyOncology
Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Anhui Huaerkang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anhui Huaerkang Pharmaceutical.

Explore the full profile